← Browse by Condition
Medical Condition
prostate cancer adenocarcinoma
Total Trials
7
Recruiting Now
7
Trial Phases
Phase 1, Phase 2, Phase 2, Phase 1
NCT07182279 Phase 1, Phase 2
Recruiting
Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer
Enrollment
29 pts
Location
United States
Sponsor
The Methodist Hospital Researc...
NCT07179783 Phase 2
Recruiting
Sacituzumab Tirumotecan in Combination With Tagitanlimab in the Treatment of Aggressive Variant Prostate Cancer (AVPC) and Neuroendocrine Prostate Cancer (NEPC)
Enrollment
28 pts
Location
China
Sponsor
Tianjin Medical University Sec...
NCT06184464
Recruiting
Prostatic Size Reduction Following of Leuprorelin Acetate
Enrollment
40 pts
Location
Spain
Sponsor
Consorci Sanitari de Terrassa
NCT07047495
Recruiting
Personalization of External Beam Radiation Therapy in Localised Tumours
Enrollment
35 pts
Location
Italy
Sponsor
European Institute of Oncology
NCT06774781
Recruiting
Assessment of ADC Values and Radiomics Characteristics With a MRI of the Prostate to Identify Tumor Lesions
Enrollment
120 pts
Location
Italy
Sponsor
IRCCS Azienda Ospedaliero-Univ...
NCT06631521 Phase 1
Recruiting
Neoadjuvant Darolutamide and Relugolix Combination Preceding Radical Prostatectomy for Prostate Cancer
Enrollment
30 pts
Location
United States
Sponsor
AdventHealth
NCT06592924 Phase 3
Recruiting
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Enrollment
830 pts
Location
United States, Canad...
Sponsor
Canadian Cancer Trials Group